Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
29.86
+0.01 (0.02%)
Aug 29, 2025, 4:00 PM - Market closed
HELX Holdings Information
HELX is an equity ETF with a total of 66 individual holdings. The top holdings are Natera stock at 6.15%, Guardant Health at 4.88%, Alnylam Pharmaceuticals at 4.84%, Medpace Holdings at 4.50%, and Insmed at 4.12%.
Total Holdings
66
Top 10 Percentage
41.64%
Asset Class
Equity
ETF Category
Health
Assets
16.41M
PE Ratio
27.70
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 6.15% |
| 2 | GH | Guardant Health, Inc. | 4.88% |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.84% |
| 4 | MEDP | Medpace Holdings, Inc. | 4.50% |
| 5 | INSM | Insmed Incorporated | 4.12% |
| 6 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 3.77% |
| 7 | n/a | Us Dollar | 3.51% |
| 8 | KRYS | Krystal Biotech, Inc. | 3.42% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.39% |
| 10 | CTVA | Corteva, Inc. | 3.07% |
| 11 | AZN | AstraZeneca PLC | 2.95% |
| 12 | BBIO | BridgeBio Pharma, Inc. | 2.85% |
| 13 | LLY | Eli Lilly and Company | 2.80% |
| 14 | UTHR | United Therapeutics Corporation | 2.65% |
| 15 | CDNS | Cadence Design Systems, Inc. | 2.43% |
| 16 | BNTX | BioNTech SE | 2.27% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.15% |
| 18 | ADPT | Adaptive Biotechnologies Corporation | 2.11% |
| 19 | LGND | Ligand Pharmaceuticals Incorporated | 2.09% |
| 20 | TEM | Tempus AI, Inc. | 2.03% |
| 21 | TMO | Thermo Fisher Scientific Inc. | 1.91% |
| 22 | ETR: SRT3 | Sartorius Aktiengesellschaft | 1.91% |
| 23 | DHR | Danaher Corporation | 1.80% |
| 24 | QGEN | Qiagen N.V. | 1.58% |
| 25 | EXAS | Exact Sciences Corporation | 1.50% |
As of Aug 29, 2025